Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00274560 · ClinicalTrials.gov registry record · Phase 3
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
A Phase 3 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 653
- Enrollment target
NCT00274560 is a Phase 3 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 653 participants.
The verdict
NCT00274560, a Phase 3 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 653 participants
- Enrollment target
Study Summary
The objective of the study was to evaluate the degree of improvement in lung function in patients with chronic obstructive pulmonary disease (COPD) after treatment with tiotropium inhalation capsules compared to salmeterol inhalation aerosol .
Interventions
- DRUG Tiotropium
- DRUG Salmeterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 653 participants |
| Start Date | 2002-05-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00274560
The ClinicalTrials.gov registry entry for NCT00274560 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tiotropium is the first listed.
NCT00274560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00274560 about?
NCT00274560 is a clinical study titled "A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.". The objective of the study was to evaluate the degree of improvement in lung function in patients with chronic obstructive pulmonary disease (COPD) after treatment with tiotropium inhalation capsules compared to salmeterol inhalation aerosol .
What is the current status of trial NCT00274560?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 653 participants. The study started on 2002-05-01.
What interventions are being tested in trial NCT00274560?
The interventions under investigation include: Tiotropium (DRUG), Salmeterol (DRUG).
Who is sponsoring clinical trial NCT00274560?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.